'%3e%3cpath%20d='M34.1406%205.85938C30.3906%202.10547%2025.3047%200%2020%200C14.6953%200%209.60938%202.10547%205.85938%205.85938C2.10938%209.61328%200%2014.6953%200%2020C0%2025.3047%202.10547%2030.3906%205.85938%2034.1406C9.61328%2037.8906%2014.6953%2040%2020%2040C25.3047%2040%2030.3906%2037.8945%2034.1406%2034.1406C37.8906%2030.3906%2040%2025.3047%2040%2020C40%2014.6953%2037.8945%209.60938%2034.1406%205.85938ZM37.0117%2023.543H31.1602V13.5391H27.6328V19.9414C28.1211%2020.6914%2028.3711%2021.582%2028.3711%2022.5625V22.625C28.3711%2023.668%2028.1172%2024.6055%2027.6328%2025.4297V26.6094H36.082C33.4883%2032.9375%2027.2891%2037.3789%2020.0039%2037.3789C10.3711%2037.3789%202.62109%2029.6289%202.62109%2020C2.62109%2010.3711%2010.3711%202.62109%2020%202.62109C29.6289%202.62109%2037.3789%2010.3711%2037.3789%2020C37.3789%2021.1484%2037.2617%2022.2656%2037.0508%2023.3477C37.0391%2023.4141%2037.0234%2023.4766%2037.0117%2023.543Z'%20fill='white'/%3e%3cpath%20d='M22.3086%2018.5352C20.4336%2018.125%2019.9531%2017.8398%2019.9766%2017.1836V17.1406C19.9766%2016.6992%2020.3477%2016.2148%2021.4023%2016.2148C22.582%2016.2148%2023.8867%2016.6797%2025.0781%2017.4766L26.8516%2015.0195C25.4453%2013.8906%2023.707%2013.3398%2021.5547%2013.3398C18.5195%2013.3398%2016.4375%2015%2016.4063%2017.4766V17.5352C16.3633%2020.2617%2018.5859%2020.9805%2021.293%2021.6016C23.0391%2021.9766%2023.5703%2022.3164%2023.5703%2022.9609L23.5469%2022.9766C23.5469%2023.3906%2023.2578%2023.7031%2022.7852%2023.8359C22.5742%2023.9062%2022.1289%2023.9727%2021.5156%2023.9727C20.7617%2023.9727%2019.7539%2023.8633%2018.6328%2023.4844C18.0898%2023.2891%2017.4727%2023.0039%2016.8047%2022.6133L20.1406%2026.625C20.2813%2026.6602%2021.0977%2026.8516%2021.7734%2026.8516C25.0039%2026.8516%2027.0859%2025.2461%2027.1094%2022.6328V22.5703C27.1602%2020.1133%2025.2148%2019.1719%2022.3086%2018.5352Z'%20fill='white'/%3e%3cpath%20d='M5.24219%2013.5664V26.6133H8.75391V23.7578L10.2969%2021.9531L14.2031%2026.6133H18.3867L12.3555%2019.5195L17.4023%2013.5664H13.4531L8.75391%2019.0586V13.5664H5.24219Z'%20fill='white'/%3e%3c/g%3e%3cdefs%3e%3cclipPath%20id='clip0_97_2430'%3e%3crect%20width='40'%20height='40'%20fill='white'/%3e%3c/clipPath%3e%3c/defs%3e%3c/svg%3e)
Lifestyle Features
Most Recent
Unilever to sell Welly bandage brand to Forward Consumer Partners
Reuters | Updated Oct. 19 - 11:30 a.m. | Save Story
Unilever said on Monday it has agreed to sell Welly Health PBC to private-equity firm Forward Consumer Partners, but did not disclose financial terms of the sale.
China's Hansoh Pharma strikes drug deal with Roche worth over $15 billion
Nichiket Sunil and Patrick Wingrove, Reuters | Updated Oct. 19 - 10:01 a.m. | Save Story
China's Hansoh Pharmaceutical said on Monday it has entered into a partnership and licensing deal with Roche potentially worth more than $15 billion that covers a portfolio of antibody-drug conjugate programs.
Trump to create new NIH division, task force for women's health
Susan Heavey and Ahmed Aboulenein, Reuters | Posted Oct. 19 - 9:45 a.m. | Save Story
President Donald Trump will sign an executive order alongside first lady Melania Trump on Monday creating a task force and a National Institutes of Health division focused on women's health, the White House said.
Germany's Merck buys Silence Therapeutics in $1.3 billion RNA drug deal
Christy Santhosh, Reuters | Updated Oct. 19 - 8:43 a.m. | Save Story
German drugmaker Merck KGaA said on Monday it would acquire UK-based Silence Therapeutics in an all-cash deal for about $1.3 billion, bolstering its pipeline of precision medicines and adding RNA-targeting drug technology.
Gilead's pill succeeds in mid-stage bowel disease trial
Reuters | Updated Oct. 19 - 8:19 a.m. | Save Story
Gilead Sciences said on Monday its experimental once-daily pill reduced symptoms of a chronic bowel illness in more patients than placebo in a mid-stage trial.
Veradermics' oral hair-loss drug shown to boost hair growth in late-stage study
Sneha S K, Reuters | Updated Oct. 19 - 7:19 a.m. | Save Story
Drug developer Veradermics said on Monday that its oral pill helped increase hair growth in men with pattern hair loss in a late-stage study.
Novartis ends mid-stage Fabhalta trial targeting serious kidney condition
Reuters | Updated Oct. 19 - 1:28 a.m. | Save Story
Swiss drugmaker Novartis has terminated a mid-stage study testing its drug Fabhalta in patients with a serious kidney condition, citing "strategic considerations", according to a federal clinical trials registry.
Roche to unveil lung, breast cancer data at ESMO 2026
Reuters | Posted Oct. 18 - 11:22 p.m. | Save Story
Roche said on Monday it will present new late-stage trial results at the ESMO 2026 cancer meeting in Madrid, including data showing its lung cancer drug divarasib worked better than current KRAS G12C treatments.
Kenya confirms eighth Ebola case as regional outbreak spreads
Reuters | Updated Oct. 18 - 2:17 p.m. | Save Story
Kenya has confirmed one more Ebola case, bringing the total number of infections in the country to eight, Director-General for Health Patrick Amoth said on Sunday.
Clearfield's new all-abilities playground opens doors for all to play
Kennedy Camarena, KSL | Posted Oct. 18 - 1:22 p.m. | Save Story
A new all-abilities playground opened up on Thursday in Clearfield, opening doors for all to play at Fisher Park.
Congo confirms Ebola outbreak has spread to eighth province
Reuters | Updated Oct. 18 - 4:04 a.m. | Save Story
The Ebola outbreak in Democratic Republic of Congo has spread to an eighth province, North Ubangi, Congo's public health institute said on Sunday, confirming earlier Reuters reporting.
AI enters the chaotic world of online dating. User beware
Sneha Dhandapani, CNN | Posted Oct. 17 - 9:17 a.m. | Save Story
Dating apps are increasingly incorporating artificial intelligence to help users find matches and craft profiles, but experts and users warn that AI-assisted dating can undermine authenticity and human connection.
KFC picks Coca-Cola as US soda supplier, ditches longtime partner PepsiCo
Juveria Tabassum, Reuters | Updated Oct. 16 - 4:05 p.m. | Save Story
Fast-food chain KFC on Thursday signed Coca-Cola as its beverage partner for U.S. stores, bringing to a close a relationship with PepsiCo that dates back about four decades.
Novartis ends mid-stage Fabhalta trial targeting serious kidney condition
Reuters | Updated Oct. 16 - 1:20 p.m. | Save Story
Swiss drugmaker Novartis has terminated a mid-stage study testing its drug Fabhalta in patients with a serious kidney condition, citing "strategic considerations", according to a federal clinical trials registry.
Kenya reports third Ebola case, a close relative of first two patients
Reuters | Updated Oct. 16 - 10:44 a.m. | Save Story
Kenya reported its third Ebola infection on Friday, in a woman it said was closely related to the first two patients.
Eli Lilly's weight-loss pill wins EU drug regulator's backing
Sriparna Roy, Reuters | Updated Oct. 16 - 9:30 a.m. | Save Story
The European Medicines Agency's committee on Friday recommended approval of Eli Lilly's weight-loss pill Foundayo, the second oral obesity drug to win the agency's backing after Novo Nordisk's Wegovy pill.
FDA flags Edwards heart-valve delivery system issue after death, injury
Reuters | Updated Oct. 16 - 8:56 a.m. | Save Story
The US FDA on Thursday warned of a potentially high-risk issue involving certain Edwards Lifesciences delivery systems used in transcatheter mitral valve replacement after one death and one serious injury.
AstraZeneca strikes $40 million AI drug discovery deal with insitro
Patrick Wingrove, Reuters | Updated Oct. 15 - 4:54 p.m. | Save Story
AstraZeneca has teamed up with artificial intelligence biotech company insitro to discover and develop new treatments for difficult to treat liver and heart conditions, the British drugmaker said on Thursday.
